Novo Nordisk AS (NVO) (Q3 2026) Earnings Call Highlights: Obesity Sales Surge 22% as Wegovy ...
TR
By Tom Reyes · Markets Editor
Nov 4 14:07 ETSource: Yahoo Finance
From the source
Read at finance.yahoo.comNovo Nordisk AS (NVO) (Q3 2026) Earnings Call Highlights: Obesity Sales Surge 22% as Wegovy ...
